BioStock: Aptahem’s new research findings explained

Aptahem’s collaboration with Örebro University recently led to a research breakthrough regarding a newfound pharmacological mechanism behind Aptahem’s sepsis treatment Apta-1. BioStock got in touch with Professor Magnus Grenegård at Örebro University to find out more about these fresh preclinical data and how they impact the further development of the drug candidate.

Read the full interview with Magnus Grenegård at biostock.se:

https://www.biostock.se/en/2021/12/aptahems-new-research-findings-explained/

This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se/

Subscribe

Quick facts

BioStock: Aptahem’s new research findings explained
Tweet this